Why the study?
Does a low-fat diet enriched in medium-chain TAG reduce plasma TAG levels in patients with type V hyperlipoproteinaemia secondary to ApoE3 (Arg 136 -> Ser) mutation?
Does a low-fat diet enriched in medium-chain TAG reduce plasma TAG levels in patients with type V hyperlipoproteinaemia secondary to ApoE3 (Arg 136 -> Ser) mutation?
The rare ApoE3 (Arg 136 -> Ser) mutation combined with ApoE2 causes severe type V hyperlipoproteinaemia with impaired exogenous TAG-rich lipoprotein clearance, which can be partially managed with a low-fat, medium-chain TAG-enriched diet.
Answers are grounded in this paper and cite their sources.
Partial TAG reduction with low-fat MCT diet in rare ApoE3 (Arg136→Ser) type V hyperlipoproteinaemia; leaves open optimal management and requires prospective validation.
This present case report describes two siblings with severe type V hyperlipoproteinaemia, diagnosed very early in life and due to the combination of the common apolipoprotein (Apo) E2 allele and rare mutant variant of ApoE, ApoE3 (Arg 136-->Ser). Phenotyping of ApoE falsely identified E2/E2 phenotype. The presence of mutated ApoE was suspected on an unusual restriction polymorphism of a Hha 1 restriction site and confirmed by sequence analysis of the cloned polymerase chain reaction fragment of exon 4 and familial segregation study. The severity of the hypertriacylglycerolaemia was modulated by the lipid content of the diet. A low-fat diet enriched in medium-chain triacylglycerol (TAG) decreased but did not normalize plasma TAG levels in both affected patients of the pedigree. A standardized lipid-enriched test meal showed a marked impairment of TAG-rich lipoprotein (TRL) clearance, especially the exogeneous TRL bearing ApoB-48 which still represented 79% of total TRL 7 h after the fat load. Finally, differences between the male and female siblings with the existence of a consanguine relationship in their parents suggested the involvement of other genetic factors in modulating the severity of phenotypic expression. This observation reinforces the usefulness of genotyping of ApoE for the characterization of genetic hypertriacylglycerolaemia and selection of the appropriate diet and treatment.
No takes yet. Share an insight, caveat, or question.
Vialettes et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: